Abstract | After decades of directed research, no effective regenerative therapy is currently available to repair the injured human heart. The epicardium, a layer of mesothelial tissue that envelops the heart in all vertebrates, has emerged as a new player in cardiac repair and regeneration. The epicardium is essential for muscle regeneration in the zebrafish model of innate heart regeneration, and the epicardium also participates in fibrotic responses in mammalian hearts. This structure serves as a source of crucial cells, such as vascular smooth muscle cells, pericytes, and fibroblasts, during heart development and repair. The epicardium also secretes factors that are essential for proliferation and survival of cardiomyocytes. In this Review , we describe recent advances in our understanding of the biology of the epicardium and the effect of these findings on the candidacy of this structure as a therapeutic target for heart repair and regeneration.
One of the most important challenges of regenerative medicine is devising how to replace the millions of cardiomyocytes that are lost after myocardial infarction (MI). In the past 2 decades, researchers have identified several potential strategies for cardiac repair, such as inducing the proliferation of existing cardiomyocytes, administering cell therapy by injecting stem cells or stem cellderived cardiomyocytes, reprogramming non-muscle cells into cardiomyocytes, applying a hypoxic environment to the heart, and applying engineered patches seeded with pro-regenerative factors [1] [2] [3] [4] [5] . However, no clinically meaningful regenerative therapy is currently available for human heart disease. Diverse approaches that combine efforts from multiple fields and use different model systems are required.
The epicardium is a thin mesothelial tissue comprising the outermost layer of the heart in vertebrates. The epicardium is a multipotent cardiac progenitor tissue and a signalling centre for heart development. Studies in the past 10 years have indicated that the epicardium might be a crucial target for cardiac repair strategies. The findings obtained in investigations exploring the epicardium of adult mouse hearts, which are poorly regenerative, have aligned with those obtained by studying the highly regenerative zebrafish [6] [7] [8] [9] [10] [11] [12] . In this Review, we discuss the models currently available to explore innate heart regeneration, the cellular and molecular contributions of epicardial cells to cardiac regeneration and scarring, the regenerative capacity of the epicardium itself, and the development of strategies to harness the properties of the epicardium to improve mammalian heart repair.
Models of heart regeneration
Functional regeneration of an injured heart is expected to involve clearance of dead tissue, restoration of lost muscle, revascularization, electrical coupling of new cardiomyocytes, and resolution of inflammation and of collagen and fibrin accumulation [13] [14] [15] [16] [17] . Of these events, the main end point is the generation of new, healthy cardiomyocytes. Although low-level cardiomyocyte proliferation has been reported in adult mammalian hearts, ostensibly too few such natural events occur to have a meaningful effect on heart repair [18] [19] [20] . In 2011, Porrello et al. performed experiments in which they removed 10% of the ventricular apex from neonatal mice of various ages 21 . The results of this study were the first to demonstrate that neonatal mice could, in the very first days of postnatal life, mount a substantial regenerative response after resection injury to yield full-size ventricles with limited scarring. Genetic fate-mapping indicated that this repair is mediated by the proliferation of existing cardiomyocytes 21 . Neonatal mouse heart regeneration has also been demonstrated after ligation of the left anterior descending artery, applied to 1-day-old mice 22, 23 . In a cryoinjury model, in which a cooled probe was applied to the ventricular surface in 1-day-old mice to induce localized cell death, hearts regenerated after nontransmural injury but not after transmural injury 24 . Not surprisingly, the regenerative capacity of the heart depends on the severity of the injury. Mice lose this cardiac regenerative capacity by 7 days of age, after which injury results in scarring. The close link between the capacity to regenerate the heart in mice and a period of massive cardiac growth as a result of cardiomyocyte
The epicardium as a hub for heart regeneration proliferation is probably not simply a coincidence 25 . Additionally, at early postnatal stages, most murine cardiomyocytes are diploid; studies in the past 2 years have associated cardiomyocyte polyploidy with the capacity of the heart for injury-induced regeneration 26, 27 . In contrast to mammals, lower vertebrates, such as zebrafish and certain urodele amphibians, possess an elevated capacity to regenerate injured heart muscle as adults 13, [28] [29] [30] [31] . Among these lower vertebrate model systems, zebrafish have been the most extensively studied because of the consistent and extensive replacement of heart muscle and the advantages of this model system for molecular genetics.
The first model of zebrafish heart regeneration was introduced >15 years ago 13 . Within 2 months of surgical removal of ~20% of the ventricular apex, the resected tissue is replaced by a wall of new muscle. This regenerative process involves rapid clotting, cardiomyocyte proliferation, and neovascularization. Collagen deposition is evident during the regeneration process, but little or no permanent scarring occurs. Resection injuries deplete muscle by direct tissue removal as well as by cell death at the injury site; therefore, a cryoinjury model was developed in 2011 to induce localized cell death in ~25% of the ventricle 16, 30 . This model better mimics MI and involves cell death, a strong inflammatory response, cardiomyocyte proliferation, and transient collagen deposition, with much of the collagen eventually clearing in 3-4 months. Coincidentally, Wang and colleagues established a genetic model to induce immediate destruction of up to ~60% of ventricular (and atrial) cardiomyocytes by expression of diphtheria toxin A 31 . This injury is limited to cardiomyocytes and has several experimental advantages: a nonsurgical, tamoxifen-activated cardiac injury with high consistency; rapid regeneration within 1 month of ablation, probably facilitated by preservation of non-myocardial scaffolding, such as the endocardium and the extracellular matrix (ECM); a diffuse injury throughout the heart that activates a regenerative response from most or all of the spared myocardium, facilitating largescale tissue collection and profiling experiments 10, 32 ; and the development of heart failure in affected animals that resolves during innate muscle regeneration 31 .
The cellular and molecular injury responses can vary between methods of cardiac injury (reviewed and compared previously 4, 33, 34 ). Studies in zebrafish have provided concepts and mechanisms germane to heart regeneration. For instance, new muscle is generated from spared, existing cardiomyocytes, which transiently dedifferentiate and proliferate, and not from stem cells. This mechanism also occurs during neonatal mouse heart regeneration. In addition, cardiomyocyte proliferation is promoted by the activities of non-muscle cells, such as endocardium, nerves, and immune cells 7, 12, 13, 17, 31, [35] [36] [37] [38] [39] [40] [41] . Most relevant to the topic of this Review, the epicardium was first implicated as a participant in heart regeneration through studies with adult zebrafish 12 .
The epicardium as a progenitor tissue Epicardium formation during development The epicardium was first described in a study of dissected chick embryos by Kurkiewicz published in 1909 (ref. 42 ). This observation was confirmed by electron microscopy studies ~60 years later 43, 44 . Further studies found that the epicardial cells are derived from a transient embryonic cell cluster called the proepicardial organ (PEO). The PEO was first described in the chick as pericardial villi that form at the venous pole of the embryonic heart tube 45, 46 . The PEO has been investigated in many other species, including zebrafish, Xenopus, axolotl, mouse, rat, and human [47] [48] [49] [50] [51] [52] [53] . The formation and cellular components of the PEO have been reviewed elsewhere 54 . Proepicardial cells were reported to translocate to the ventricular surface by direct PEOchamber contact and/or by release of proepicardial cells into the pericardial cavity and adherence to the ventricle, depending on the species and approaches that were used 49, 50, 52, [55] [56] [57] [58] . By live surveillance of PEO formation and proepicardial cell translocation in zebrafish embryos, Peralta and colleagues defined three clusters of epicardial precursor cells, one located at the level of the atrioventricular canal, one adjacent to the venous pole, and one that directly contacts the myocardium (located at a region of the pericardial mesothelium close to the arterial pole) 55 . Cells from the first two proepicardial clusters adhere to the ventricle at 60-72 h after fertilization. After translocation to the myocardial surface, proepicardial cells expand over the surfaces of ventricle, atrium, and outflow tract (or bulbous arteriosus) to form a contiguous epicardial sheet. During development, a subset of epicardial cells delaminates from the epicardium and undergoes epithelial-to-mesenchymal transition (EMT). During EMT, these cells migrate to the subepicardial space, where they give rise to a variety of cell types, often referred to collectively as epicardium-derived cells (EPDCs) 59 .
Cell contributions in higher vertebrates
Early studies in chick embryos used dyes to label epicardial cells, employed cell transplantation in chimaeras containing quail cells, and tagged epicardial cells with retroviral vectors. These approaches all indicated that the epicardium contributes to vascular smooth muscle cells and cardiac fibroblasts during avian heart development (Table 1) . More controversial findings indicated contributions to endothelial and endocardial cells in chick embryos [60] [61] [62] [63] [64] [65] [66] [67] . These approaches in avian models might have limitations in efficiency, specificity, and interpretation.
Key points
• The epicardium is a layer of mesothelial tissue that envelops the heart in all vertebrates.
• The epicardium contributes essential cells and signals during heart development and regeneration.
• The epicardium comprises a heterogeneous cell population and is a highly regenerative tissue.
• The epicardium is required for normal myocardial regeneration in zebrafish.
• Current research approaches aim to activate the adult epicardium to promote heart regeneration.
Diploid
Containing two complete sets of chromosomes.
A contemporary approach to assess cell fates in several model systems is genetic fate-mapping, which requires the use of specific regulatory sequences to induce a permanent label within a candidate progenitor cell population and its progeny in transgenic animals. In these experiments, a regulatory sequence-driven cassette that harbours a tamoxifen-inducible Cre recombinase (CreER) is often used in conjunction with a gene encoding a fluorescent reporter that is normally kept inactive by an upstream loxP-flanked stop sequence separating the reporter gene from a constitutive promoter. Importantly, no gene regulatory sequences are known to direct gene expression that is absolutely restricted to the epicardium. However, several markers of the epicardium (and of other tissues) have been employed to permanently label and trace epicardial cells in mice. Scx, Sema3d, Tbx18, Tcf21, and Wt1 are all expressed in the epicardium, but their regulatory sequences also mark additional cell populations [68] [69] [70] [71] [72] [73] [74] [75] . The reliance on a set of regulatory sequences to infer cell lineage relationships is a pitfall of using Cre and CreER reporter lines for tracing epicardial cell fates. Other caveats include the persistence of the inducer tamoxifen within the animal, the toxicity of Cre recombinase in some cell types, the observation that direct knock-in of a Cre gene cassette typically disrupts one allele by co-opting its endogenous The study was focused on a particular cell fate, and other cell types were not reported.
Knock-in
a genetic engineering method to insert an exogenous sequence or to replace the endogenous sequence in a given locus of the genome. NaTuRe Reviews | Cardiology volume 15 | oCToBeR 2018 | 633 regulatory sequences, and the possibility that the constitutive promoter might not be expressed and reveal the trace in all progeny of a labelled progenitor cell [76] [77] [78] [79] [80] [81] . In mice, fate-mapping studies have indicated that epicardial cells are a major source of cardiac fibroblasts during heart development 68, 72, [82] [83] [84] (Table 1) . Murine epicardial cells also differentiate into vascular smooth muscle cells and pericytes that help to construct the coronary vasculature 68, 69, 72, 84, 85 (Table 1) . Epicardial contributions to cardiac endothelium and endocardium were reported when assessing the lineages of Scx-expressing and Sema3d-expressing cells in mice 72 , although such contributions were suggested to be rare, if at all present, in other studies 68, 69, 84 . In addition, a lineage-tracing study using a Tbx18-Cre mouse strain showed that the epicardium is the origin of the cardiac adipose tissue 86 . An intriguing question over the past decade has been whether the epicardium contributes cardiomyocytes during development or regeneration. Whereas initial fate-mapping studies supported this idea 68, 69 , the tools involved for fate-mapping with Tbx18 or Wt1 regulatory sequences were subsequently reported to label other cardiac cells, including cardiomyocytes themselves 70, 71 . Another study also reported rare myocardial contributions by the cell lineages of the Scx-expressing and Sema3d-expressing epicardial cells 72 . The current consensus view is that the contribution of epicardium to myocardium is minimal, if it occurs at all, in mice.
Following cardiac injury, lineage-tracing studies in mice have demonstrated that adult epicardial cells contribute to vascular smooth muscle cells and pericytes within the infarct; fibroblasts, which proliferate extensively and generate scar tissue, are the principal progeny 9,87-90 ( fig. 1 ; Table 1 ). Besides the epicardium, diverse sources of cardiac fibroblasts, such as the endothelium, haematopoietic cells, and perivascular cells, have been proposed in different cardiac injury contexts. Although the accurate origin of cardiac fibroblasts after injury is debatable and under investigation, cardiac fibroblasts are widely accepted to be a heterogeneous cell population with multiple origins in injury contexts, with the epicardium as a confirmed source (reviewed previously [91] [92] [93] ). The properties and predominance of fibroblasts in MI have suggested innovative approaches designed to reprogramme them into cardiomyocyte-like cells [94] [95] [96] [97] . Current reprogramming approaches involve the infection of fibroblasts in the infarct area with retroviruses containing the genes encoding cardiac transcription factors, such as GATA4, T-box transcription factor TBX5, heart and neural crest derivatives-expressed protein 2 (HAND2), and myocyte-specific enhancer factor 2 C (MEF2C), with or without small molecules that might increase efficiency 98 ( fig. 1 ). The chief hurdle of in vivo reprogramming is the very low reprogramming efficiency of current approaches, although rapid maturation and incorporation of de novo cardiomyocytes are additional challenges. Future translational advances might also require the identification of specific fibroblast subsets with high reprogramming potential and/or supplementation with cardiomyocyte mitogenic factors. This topic is reviewed elsewhere in this Focus issue 99, 100 . Most fate-mapping studies using Cre recombinase or CreER reporter lines driven by Wt1 regulatory sequences have indicated that epicardial cells are progenitors of new smooth muscle cells 9, 87, 88, 90 (Table 1 ) and pericytes 9, 89 after MI. Epicardial contribution to coronary endothelial cells was reported in one study using a Wt1 bacterial artificial chromosome (BAC) reporter (Wt1 GFPCre ) 88 but was not detected in other studies using transgenic knock-in strains (Wt1 CreERT2 ) 9, 87 . Later studies using in situ hybridization, antibody staining, and lineage tracing (with Wt1
CreGFP or Wt1 CreERT2 knock-in strains) identified Wt1 expression in coronary endothelial cells during development and in adult hearts before and after MI 70, 101 , undermining evidence showing that epicardial cells are precursors to endothelial cells. However, the endothelial lineage could be promoted in one study by intramyocardial injection of vascular endothelial growth factor A (VEGFA) into adult mouse hearts after MI (detailed below) 90 . In addition, Wt1 + cells were reported to give rise to cardiac adipose tissue after MI in mice, an intriguing potential function for adult epicardial cells that might recapitulate earlier roles in development 102, 103 . Epicardial cells are not an innate source of cardiomyocytes during mammalian cardiac repair, but it is conceivable that myogenic properties could be induced in these cells, as described earlier, for their fibroblast progeny in reprogramming contexts. Interestingly, thymosin β 4 was reported as a regeneration factor that can reactivate mouse epicardial cells, causing them to differentiate into myocytes at low frequency 8, 11 . In a 2011 study, thymosin β 4 -activated Wt1 + cells proliferated and expressed Isl1 (a marker of postnatal cardioblasts) and Nkx2-5 (an early marker of cardiomyocyte progenitors), with a cell subset further differentiated into cardiomyocytes 8 . Importantly, with respect to potential clinical translation, thymosin β 4 induced cardiomyocyte potency in Wt1 + cells only when administered before MI, whereas another study in which thymosin β 4 was administered after MI did not identify epicardial-to-myocardial transitions 87 . Additional In situ hybridization a biochemical method that uses labelled complementary nucleic acids to visualize specific nucleic acid sequences in tissues.
epicardial fate-mapping experiments with a new generation of fate-mapping tools will aid the interpretation of such rare transdifferentiation events 104 .
Cell contributions in zebrafish
In zebrafish, the regulatory sequences of tbx18, tcf21, and wt1 have been widely used to visualize epicardial cells in transgenic reporter strains 7, 16, 105 . Among these sequences, tcf21 is most widely and preferentially expressed in epicardial cells during development, at the adult stage, and during regeneration. By contrast, tbx18-driven or wt1-driven reporters do not label epicardial cells at all stages and show some expression in cardiomyocytes during development and regeneration 7 . Additionally, cav1 regulatory sequences label epicardial cells and EPDCs in addition to endocardial and endothelial cells 106 , and fn1a regulatory sequences label a subset of epicardial cells after cardiac injury 10 . Finally, the gene-trap line Et(krt4: EGFP) sqet27 has reporter expression in epicardium and bulbous arteriosus cells 107, 108 ; however, the full spectrum of tissue expression has not been reported. Genetic lineage-tracing experiments performed using the tcf21:CreER transgenic zebrafish indicated that epicardial cells contribute to perivascular support cells in the developing and regenerating zebrafish heart 7 ( fig. 1 ; Table 1 ). In a subsequent study using cell transplantation, wt1b:GFP-labelled epicardial cells were found to contribute to myofibroblasts and perivascular fibroblasts in cryoinjured zebrafish hearts 37 . Zebrafish show a rapid, extensive vascularization of regenerating muscle after cardiac injury 12, 14 , and evidence shows that epicardial generation of support cells facilitates or stabilizes this response 7, 40 . Notably, lineage-tracing data indicated no evidence that zebrafish epicardial cells can generate cardiomyocytes during heart development or regeneration, even in rare events 7, 37 . Thus, innate heart regeneration does not seem to involve transdifferentiation from epicardium to myocardium.
Fibroblasts in the zebrafish heart have not been extensively studied but are less prominent than in thickwalled mammalian hearts 77 . In the cardiac cryoinjury model of zebrafish, a cell population characterized by staining for intermediate filament vimentin, extracellular de-adhesive protein tenascin C (Tnc), actin, α2, smooth muscle, aorta (Acta2; also known as α-smooth muscle actin), and myosin light chain kinase (Mylk) appeared transiently during regeneration 16, 30 . The results of these studies suggest that fibroblasts deposit collagen after heart injury, although these markers can label other cardiac cell types 93, [109] [110] [111] . Cell transplantation of wt1b + EPDCs suggested epicardial contributions to fibroblasts expressing the markers col1a2 and postnb in addition to perivascular cells 37 . Accumulating evidence indicates that epicardial cells have high cellular plasticity. Some debate over the precise contribution of epicardial lineages in higher and lower vertebrates will continue as more specific makers are identified, although for the most part, a consensus has been reached on what cell types to which epicardial cells do (perivascular cells) and do not (cardiomyocytes) give rise. Enhancing the perivascular lineage while restraining the fibroblast lineage is one objective that would benefit cardiac repair -a goal that would be aided by further knowledge of crucial factors in epicardial lineage commitment.
Epicardial cellular heterogeneity
Because of the different progeny cell types revealed by fate-mapping of epicardial cells in mice, chicks, and zebrafish, most researchers agree that the epicardium is probably a heterogeneous grouping of multiple cell subpopulations. A study in mice revealed that thymosin β 4 -reactivated EPDCs labelled with a Wt1 lineage trace are a heterogeneous cell population 112 . Characterization with quantitative PCR and immunostaining of thymosin β 4 -primed EPDCs isolated from the infarct area showed that adult reactivated green fluorescent protein-positive (GFP + ) EPDCs are a heterogeneous cell population with a variety of cardiovascular potentials. These cells had restored expression of some embryonic genes but had an expression profile distinct from that of embryonic epicardial cells analysed at embryonic day 12.5 (E12.5). The Sca1 + cell subset had the most strongly activated developmental programme (expressing Pdgfrb, Raldh2 (also known as Aldh1a2), Tbx18, and Wt1) and cardiac progenitor marker expression (such as Acta2, Fap, Gata4, Isl1, Kdr (also known as Flk1), Pecam1, and Tagln (also known as Sm22a)). The results of this study suggested that identifying particular subpopulations of EPDCs is clinically important for therapeutic approaches that involve manipulating the epicardium.
Contemporary technology to assess genome-wide changes in transcription in individual cells has enabled the delineation of cell subpopulations in many tissues and species [113] [114] [115] [116] [117] . A single-cell transcriptome study in zebrafish revealed some heterogeneity of tcf21-expressing cells purified from uninjured adult hearts 106 . This analysis suggested the presence of multiple cell subsets, each defined by a specific expression signature, as well as genes that might represent cell subset-specific markers. Further validation of markers from studies such as this one might provide new reporters and tools that will improve lineage-tracing experiments. Moreover, whereas this study examined the transcriptomes of only a few dozen cells, economically assessing tens of thousands of cells is now possible for a much higher resolution assessment of cell heterogeneity. Additionally, profiling epicardial cells collected from injured hearts can answer the question of whether notable changes in cell heterogeneity occur during cardiac regeneration.
Epicardial signals in heart regeneration Activation of the epicardium by injury A growing number of studies over the past decade have employed animal model systems to identify mechanisms by which epicardial tissue influences heart repair. Following cardiac injury, epicardial cells induce the expression of genes that mark the embryonic epicardium, proliferate, and cover the injury site, a process referred to as activation. In zebrafish, virtually the entire epicardium is activated within 1-2 days of injury ( fig. 2a) , expressing markers such as fn1a, raldh2, tbx18, and wt1 (refs 10,12,16,31,40,105,118 ) . In a zebrafish model of resection injury, developmentally activated epicardial cells become confined to the injured area at 7 days after amputation 12, 40 ( fig. 2a) . In neonatal mice, apical resection was similarly associated with rapid epicardial activation, indicated by the induction of Raldh2 and Wt1 in an organ-wide manner 21, 119 . In adult mice, cardiac injury also provoked re-expression of embryonic epicardial markers 6, 9, 87, 88 . The molecular mechanisms by which heart injury activates the epicardium (especially in an organ-wide manner) are likely to be fascinating but are still poorly understood. Huang et al. approached this question by assessing the conservation of potential DNA regulatory elements near genes that mark the embryonic epicardium in mice 6 . The investigators identified the CCAAT/enhancer-binding protein (C/EBP) family of transcription factors as regulators of Raldh2 and Wt1 expression in embryonic hearts and in adult hearts after MI, through binding to enhancer elements near these genes 6 . A 2017 study identified transcription activator BRG1, a catalytic subunit of the SWI/SNF chromatin-remodelling complex that has epicardial expression during heart development and after heart injury, as a regulator of Wt1 expression and epicardial activation in mice 120 . Evolutionary conserved regions in the Wt1 locus are responsible for regulating Wt1 expression. BRG1 is recruited by C/EBPβ to these conserved regulatory elements in the Wt1 locus, which is required for Wt1 expression. Interestingly, thymosin β 4 interacts with BRG1 and augments Wt1 expression after MI 120 . Additional evidence has suggested that epicardial activation amplifies the inflammatory response. After ischaemia-reperfusion injury in mice, neutrophils were observed on the epicardial surface, in the subepicardial space, and in the infarct area 6 . Viral expression of a dominant-negative variant of C/EBP in the adult epicardium decreased the number of neutrophils, suggesting a function of C/EBP transcription factors in regulating neutrophil infiltration 6 . Mice with epicardial deficiency in Yes-associated protein 1 (YAP1) and transcriptional coactivator with PDZ-binding motif (TAZ; also known , and wt1 (green cells), occurs across the whole organ 1 day after resection of the ventricular apex, but is restricted to the injury site at 7 days after injury. b | Proposed epicardium-myocardium signals in zebrafish heart regeneration and mammalian heart repair. Bmp, bone morphogenetic protein; Bmpr, bone morphogenetic protein receptor ; ERBB, receptor tyrosine kinase ERBB; FGF, fibroblast growth factor ; FGFR , fibroblast growth factor receptor ; FSTL1, follistatin-related protein 1; Igf2b, insulin-like growth factor 2; IGF1R , insulin-like growth factor 1 receptor ; NRG1, neuregulin 1; Pdgfβ, platelet-derived growth factor-β; Pdgfrβ, platelet-derived growth factor receptor-β; pSmad, phosphorylated mothers against decapentaplegic homologue; Ptch2, protein patched homologue 2; RA , retinoic acid; RALDH2, retinaldehyde dehydrogenase 2; RXRα, retinoic X receptor-α; Shh, sonic hedgehog; Tβ4, thymosin β 4 ; TGFβ, transforming growth factor-β; Tgfbr1b, transforming growth factor-β receptor 1b (also known as Alk5b).
www.nature.com/nrcardio 636 | oCToBeR 2018 | volume 15 r e v i e w s as WWTR1) had profound pericardial inflammation caused by a decrease in the number of regulatory T (T reg ) cells in the injured myocardium 121 . In addition, the close connection of the epicardium with macrophages suggests a link to epicardial cell activation 122, 123 . Identification of intrinsic programmes in epicardial cells and extrinsic factors (for example, from macrophages) that activate the epicardium will stimulate new discoveries in biology and potential therapeutic strategies.
Signalling interactions with the myocardium
When activated, the epicardium secretes signals with the potential to influence heart regeneration 9, 124, 125 . The epicardium has been proposed to stimulate cardiomyocyte proliferation during both embryonic heart development and adult heart regeneration. The epicardium also contributes ECM components and growth factors to maintain cardiac tissue structure and electrophysiological properties 93, 126 . Multiple signalling pathways mediate interactions between epicardium and myocardium, as reviewed elsewhere in the context of heart development 127, 128 . In this Review, we provide snapshots of signals that have been reported to be involved in cardiac repair ( fig. 2b ; Table 2 ).
Retinoic acid. Retinoic acid (RA) signalling is critical for zebrafish heart regeneration. Retinaldehyde dehydrogenase 2 (Raldh2) is the rate-limiting enzyme for RA synthesis, and raldh2 expression is induced by injury in both the epicardium and endocardium 12 . Inhibition of RA signalling in zebrafish by overexpressing a dominantnegative variant of the RA receptor RARα or by overexpressing cyp26a1 (which encodes a RA-degrading enzyme) blocks cardiomyocyte proliferation and heart regeneration 40 . However, in this study, RA signalling was inhibited systemically; thus, how RA acts directly on cardiomyocytes remains unclear. In studies of neonatal mouse heart regeneration, Raldh2 expression was also induced by resection injury, presumably in the epicardium, although the expression domain of Raldh2 was not assessed 21 . In adult mouse hearts, expression of Raldh2 is induced by MI in the epicardium but not in the endocardium 88, 129 . RXRα signalling in mouse epicardium is required for myocardial growth and coronary artery formation 130 , suggesting a potential role of RA signalling in mammalian heart regeneration that has not been directly explored.
Fibroblast growth factor. Fibroblast growth factor (Fgf) signalling is also required for zebrafish heart regeneration. Following cardiac amputation injury, expression of fgf17, which encodes the ligand Fgf17, is induced in cardiomyocytes, whereas fgfr2 and fgfr4, which encode Fgf receptors, are induced in EPDCs. Induced expression of a dominant-negative fgfr1 construct blocked epicardial cell EMT, coronary neovascularization, and muscle regeneration 12 . After MI in rats, the FGF1 level is upregulated in inflammatory cells and fibroblast-like cells in the border zone of infarcted myocardium, whereas FGF2 is induced in both the border zone (primarily in endothelial cells) and the infarct area (in cardiomyocytes) 131 . FGF receptor signalling in muscle is required for the normal response to MI in rats 131 , and FGF has been widely examined for potential therapeutic applications in cardiovascular disease (reviewed previously 132, 133 ); however, the roles of this pathway in the mammalian epicardial response to heart injury require further investigation.
Transforming growth factor-β. Following cardiac injury in zebrafish, expression of tgfb1, tgfb2, and tgfb3 is broadly induced in epicardial cells, fibroblast-like cells, and cardiomyocytes, whereas the expression of tgfbr1b, encoding a receptor for transforming growth factor-β (Tgfβ), is induced in cardiomyocytes and fibroblast-like cells 134 . The presence of phosphorylated mothers against decapentaplegic homologue 3 (Smad3; also known as MAD homologue), an indicator of active Tgfβ signalling, is evident in cardiomyocytes and non-cardiomyocytes in the infarct area 106, 134 . Pharmacologically inhibiting the Tgfβ pathway in zebrafish impaired ECM deposition and cardiomyocyte proliferation, consequently disrupting regeneration 134 . In adult rats and pigs, expression of Tgfb1, Tgfb2, and Tgfb3 is sharply induced in the infarcted myocardium [135] [136] [137] . Considering the multifarious roles of TGFβ signalling in cardiovascular development and disease 138 , this pathway must be explored methodically for cell-type-specific and isoform-specific functions in the response to cardiac injury. A 2017 study in zebrafish identified two activin type 2 receptor ligands of the TGFβ family, myostatin b (Mstnb) and inhibin subunit β Aa (Inhbaa), that exerted opposing effects on cardiomyocyte proliferation and heart regeneration 139 . Overexpression of inhbaa increased the rate of cardiomyocyte proliferation. By contrast, overexpression of mstnb or deletion of inhbaa suppressed cardiomyocyte proliferation and impaired heart regeneration 139 . Notch signalling. In zebrafish, notch1a, notch1b, notch2, and notch3 are expressed in the endocardium 140 . After cardiac resection injury, expression of notch1a, notch1b, and notch2 is predominantly upregulated in the endocardium, and notch1a and notch2 expression is also sharply induced in the epicardium 140 . Expression of notch3 is not changed. After heart cryoinjury in zebrafish, expression of notch1b, notch2, notch3, and dll4, which encodes the Notch ligand Delta-like 4, is induced in endocardial cells adjacent to the wound 141 . Transgenic inhibition of Notch signalling impaired heart regeneration, coincident with decreased cardiomyocyte proliferation. Interestingly, transgenic hyperactivation of Notch signalling, through overexpression of the Notch intracellular domain (NICD), suppressed cardiomyocyte proliferation and heart regeneration in the zebrafish resection model, whereas NICD overexpression augmented cardiomyocyte proliferation in the zebrafish cryoinjury model 140, 141 . Whether this difference is attributable to the different injury models, to the expression levels of NICD, or to other factors is unclear. Similarly, Notch signalling is activated in cardiomyocytes, epicardial cells, and EPDCs after MI in mice 142, 143 . Inducible overexpression of NICD1 in adult cardiomyocytes after MI increased the percentage of cardiomyocytes positive for the cell cycle active phase marker Ki67 but not of cardiomyocytes positive for the proliferation marker phosphorylated r e v i e w s histone 3, and the researchers proposed a role for Notch signalling in promoting cardiomyocyte survival 143 . Perhaps unsurprisingly, these studies in both zebrafish and mouse models suggest that Notch signalling activity must be fine-tuned for positive effects on heart repair.
Nuclear factor-κB signalling. In zebrafish, expression of nfkb1, nfkbiaa, and nfkbiab is induced in cardiomyocytes after resection injury 144 . Suppressing nuclear factor-κB (NF-κB) signalling by induced expression in cardiomyocytes of a super-repressor variant of the NF-κB inhibitor IκB impaired epicardial cell colonization of wounds, cardiomyocyte proliferation, and heart regeneration. The researchers suggested that NF-κB contributes to crosstalk between cardiomyocytes and epicardial cells, which has yet to be explored at the molecular level 144 .
Platelet-derived growth factors. After resection injury in zebrafish, expression of pdgfrb, encoding plateletderived growth factor receptor-β (Pdgfrβ), is induced in the epicardium and in cells within fibrin clots at the wound site, whereas expression of pdgfb, encoding the ligand platelet-derived growth factor-β (Pdgfβ), is induced in thrombocytes 41 . Pdgf signalling induced proliferation of zebrafish epicardial cells in vitro, and pharmacological inhibition of Pdgf signalling in vivo suppressed coronary blood vessel formation during heart regeneration 41 . After MI in mice, expression of Pdgfb, Pdgfra, and Pdgfrb is induced in the infarct area, and PDGFRβ is phosphorylated (an indicator of active signalling) in perivascular cells within the infarct zone 145 . Antibody blockade of PDGFRα and PDGFRβ decreased collagen deposition and impaired vascular maturation in the infarct zone 145 .
WNT-β-catenin signalling. Following MI injury in mice, expression of Wnt1, encoding the ligand WNT1, is induced in the epicardium and cardiac fibroblasts in the region of injury 146 . Deficiency of β-catenin in epicardial cells disrupted epicardial cell expansion and EMT and decreased heart function after MI. Moreover, β-catenin deficiency in cardiac fibroblasts led to acute cardiac dilatation and cardiac dysfunction 146 . Another report showed that expression of Wnt10b is transiently induced in mouse cardiomyocytes in the peri-infarct area after MI, a response that the researchers suggested Rat and pig Tgfb1, Tgfb2, and Tgfb3: infarcted myocardium NA [135] [136] [137] WNT Mouse •Wnt1: epicardium and fibroblasts •Wnt10b: cardiomyocyte in the peri-infarct area
• Deleting β-catenin in the epicardium disrupted epicardial cell expansion and EMT and decreased heart function after MI • Deleting β-catenin in cardiac fibroblasts led to acute cardiac dilatation and cardiac dysfunction • Wnt10b overexpression increased neovascularization of scar tissue and attenuated fibrosis 146, 147 BMP, bone morphogenetic protein; Cxcl12a, CXC-chemokine ligand 12a; Cxcr, CXC-chemokine receptor ; ECM, extracellular matrix; EMT, epithelial-to-mesenchymal transition; EPDC, epicardium-derived cell; FGF, fibroblast growth factor ; FSTL1, follistatin-related protein 1; IGF, insulin-like growth factor ; IGF1R , insulin-like growth factor 1 receptor ; MI, myocardial infarction; NA , not available; NRG1, neuregulin 1; NF-κB, nuclear factor-κB; NICD, Notch intracellular domain; PDGF, platelet-derived growth factor ; PDGFR , platelet-derived growth factor receptor ; pSmad, phosphorylated mothers against decapentaplegic homologue; RXRα, retinoic X receptor-α; Tβ4, thymosin β 4 ; TGFβ, transforming growth factor-β; RT-PCR , reverse transcription-PCR; TAZ, transcriptional coactivator with PDZ-binding motif (also known as WWTR1); YAP1, Yes-associated protein 1. a Non-injury-related expression and downregulation are listed in brackets. coordinates arterial formation and attenuates fibrosis 147 . Dissecting the functions of this signalling protein family in zebrafish and neonatal mouse regeneration models will be intriguing.
Hedgehog signalling. This pathway was implicated in heart regeneration in a screen of potential cardiomyocyte mitogens performed in zebrafish embryos with the use of a transgenic reporter system that enables live visual detection of proliferating cardiomyocytes. In zebrafish, regulatory sequences of shha, a gene encoding a Hedgehog ligand, are activated in epicardial tissue adjacent to and within the injury site at 7 days after partial ventricular resection, whereas activation of a reporter that reflects the expression of the Hedgehog target gene ptch2 is present in cardiomyocytes within the area of regeneration 39 . The results of pharmacological manipulations of Hedgehog and of epicardial-specific deletion of shha (by combining a Cre-dependent invertible gene-trap cassette with the tcf21:CreER line) in zebrafish suggested that Hedgehog signalling promotes cardiomyocyte proliferation during regeneration 39, 148 . As indicated below, Hedgehog signalling has also been reported to regulate epicardial cell regeneration 149 . Hedgehog signalling has been implicated in mammalian epicardial biology during cardiac development and homeostasis, where Hedgehog was suggested to be a potential therapeutic target for ischaemic heart disease [150] [151] [152] .
Insulin-like growth factor. In the same screen for cardiomyocyte mitogens in zebrafish described above, treatment with the insulin-like growth factor (Igf) signalling agonist NBI-31772 increased cardiomyocyte proliferation in the developing heart 39 . Expression of the gene encoding the ligand Igf2b was found to be induced in adult endocardial and epicardial cells in the injury site 7 days after injury, whereas the gene encoding the receptor Igf1r was expressed in cardiomyocytes. Pharmacological inhibition of Igf signalling in zebra fish decreased cardiomyocyte proliferation and impaired heart regeneration, whereas an Igf signalling agonist increased proliferation 39 . Similar results were reported in another study, which also used a dominant-negative form of Igf1r to block Igf signalling and heart regeneration in zebrafish 153 . In addition, Igf1r is expressed in murine Wt1 + epicardial cells, and inhibition of IGF1R in Wt1 + lineages after MI reduced adipogenic differentiation 102 .
Bone morphogenetic protein.
The function of bone morphogenetic protein (BMP) signalling in cardiac repair might differ between mice and zebrafish. By using a spatially resolved, RNA-sequencing technique called tomo-seq, Wu et al. generated a spatiotemporal landscape of gene expression in the regenerating zebrafish heart after cryoinjury, revealing multiple genes in the BMP pathway with differential expression at the injury region 108 . Expression of bmp2b and bmp7 was induced in the epicardium and endocardium; id2b in the endocardium; and bmpr1aa in the wound border zone. Phosphorylated Smad1, Smad5, and Smad8 -an indicator of signalling activation -were detected in cardiomyocytes in the wound area 108 . Overexpression of noggin3, which encodes a BMP antagonist, decreased cardiomyocyte dedifferentiation and proliferation and increased scarring, whereas overexpression of bmp2b had the opposite effect. In addition, bmpr1aa zebrafish mutants showed reduced cardiomyocyte proliferation upon injury 108 . By contrast, both mice with inhibited BMP signalling (through overexpression of Noggin or with pharmacological treatment) and Bmp4 +/− mice had reduced infarct size and cardio myocyte apoptosis after ischaemia-reperfusion injury 154 . These studies suggest that species-specific responses to the same activated signalling pathways dictate the primary outcome of cardiac injury, an inference that needs further investigation.
Hippo-YAP signalling. The Hippo-YAP pathway has been proposed to regulate cardiomyocyte proliferation during mammalian life. Indeed, multiple reports now indicate that derepression of YAP1 and its capacity to bind target genes can have dramatic effects on cardiomyocyte proliferation, even in the adult stage [155] [156] [157] [158] [159] . During murine heart development, Hippo pathway genes (Yap, Taz, Tead1-Tead3, Lats1, and Lats2) are also expressed in the proepicardium and epicardium, and YAP1 and TAZ are required in the epicardium for coronary vasculature development 160 . Deletion of Lats1 and Lats2 in mouse embryonic (E11.5) epicardium with the use of the Wt1
CreERT2 knock-in allele reduced epicardialto-fibroblast differentiation events 161 . Single-cell RNAsequencing assays suggested that Lats1 and Lats2 deletion preserved epicardial gene expression profiles and elevated the expression of YAP1 target genes, such as Dhrs3, which encodes the negative regulator of RA synthesis short-chain dehydrogenase/reductase (SDR family) member 3, and Dpp4, which encodes the ECM regulator dipeptidyl peptidase 4. Whether epicardial Hippo-YAP signalling components are regulated by cardiac injury has not been investigated. As described above, deletion of Yap and Taz in the mouse epicardium induced profound pericardial inflammation, myocardial fibrosis, cardiomyopathy, and death after MI 121 . This finding further supports the concept that the epicardium mediates inflammatory responses after MI.
Chemokines. Following resection injury in zebrafish, expression of the marker cxcl12a, which encodes the CXC-chemokine ligand 12a, is induced in epicardial tissue, whereas cxcr4b, encoding the CXC-chemokine receptor 4b, is expressed in cardiomyocytes 162 . An antagonist that blocks Cxcr4 function disrupted heart regeneration, and the researchers suggested that this effect was the result of impaired cardiomyocyte migration to the injury site 162 . This study was the first to propose that cardiomyocyte migration is an essential mechanism in heart regeneration. Of note, a later study reported that myocardial Cxcl12b signalling and endothelial Cxcr4a signalling were important in guiding coronary vessel development in zebrafish and that a cxcr4a mutant showed defects in heart regeneration 163 . The regeneration phenotype was proposed to be a secondary outcome of defects in coronary vessel patterning. These studies suggest that the zebrafish heart harnesses www.nature.com/nrcardiodifferent Cxcl12 and Cxcr4 systems for development and regeneration. Neuregulin 1. Neuregulin 1 (Nrg1) is an extracellular factor that acts as an endothelial-cell-derived mitogen for mammalian cardiomyocytes 164, 165 . In the adult zebrafish heart, tcf21 + epicardium-derived perivascular cells induce nrg1 expression after cardiac injury, although nrg1 levels remain low overall 106, 166 . Pharmacological blockade of the Nrg1 ErbB receptors in zebrafish decreased injury-induced cardiomyocyte proliferation, whereas overexpressing nrg1 in cardiomyocytes increased cardiomyocyte proliferation and caused cardiomegaly in the absence of injury 166 . Injury-induced, transgenic overexpression of nrg1 in endocardium and epicardium, through a leptinb-linked enhancer element, also boosted cardiomyocyte proliferation in zebrafish 167 . In addition, T reg -like cells that home to injury sites were identified as a source of Nrg1 during zebrafish heart regeneration 35 . Thus, Nrg1 is a potent, inducible mitogen in zebrafish cardiomyocytes, and the epicardium and T reg -like cells seem to be the primary sources of Nrg1. Of note, NRG1 might effectively induce cell division only in mononucleated and/or diploid cardiomyocytes 164 , potentially limiting the therapeutic potential of NRG1 for the human injured heart. In addition, current evidence does not exclude the possibility that ERBB pathway ligands other than NRG1 might act as ancillary or primary mitogens during heart regeneration.
Other factors. As discussed above and below, thymosin β 4 and follistatin-related protein 1 (FSTL1) are reported to be involved in epicardium-myocardium interactions that benefit heart repair 8, 11, 87, 168, 169 . In addition, caveolin 1 -a component of caveolae that is predominantly expressed in epicardial cells and EPDCs but also in coronary vascular endothelial cells -was shown to be required for cardiomyocyte proliferation and heart regeneration in adult zebrafish 106 . The results of that study suggested that signal transduction via caveolae is likely to be critical for epicardium-cardiomyocyte interactions.
Production of ECM components
The ECM is a noncellular component secreted by cells to provide chemical and mechanical cues to surrounding cells 170 . ECM supports cell proliferation and maturation in addition to tissue organization during heart development [171] [172] [173] [174] . Accumulating evidence suggests that epicardial and fibroblast ECM remodelling is involved in heart development and regeneration and that manipulating the deposition of epicardial ECM influences regeneration. For example, during mouse heart development, inhibiting α4-integrin signalling stimulated epicardial EMT and altered epicardial lineages 175 . The developing and adult murine epicardium is surrounded by ECM components (such as fibronectin, collagen type IV, and hyaluronic acid), which are broken down and re-form after MI 176 . In zebrafish, expression of the genes encoding the ECM components fn1 and fn1b is induced in epicardial cells following cardiac resection injury 10 . Expression of fn1 and fibronectin deposition are dynamic events, occurring first chamber-wide and then becoming localized to the injury site. Expression of the gene encoding the fibronectin receptor integrin-β3, itgb3, is induced in cardiomyocytes near the injury site, suggesting a possible epicardial-myocardial interaction. Mutation of fn1 or induced expression of a dominant-negative fn1 cassette disrupted heart regeneration and led to scar formation in zebrafish. Further analyses suggested that cardiomyocyte proliferation was not affected in either of these experiments, and the researchers speculated on possible roles of fibronectin in cardiomyocyte patterning or displacement 10 . Similarly, in a newt heart regeneration model, ECM deposition (fibronectin, hyaluronic acid, and tenascin C) by epicardial cells was induced organwide after resection injury before becoming restricted to the injury site 29 . In this study, the researchers hypothesized that unspecified proliferating cells within the heart migrate to the ECM-rich epicardial sheath and then to the regenerating ventricular apex 29 . Although the mechanisms underlying these processes need further clarification, the results of these two studies suggest that the epicardium helps to establish an ECM environment that supports heart regeneration.
Additional studies have identified epicardial-derived ECM components that might be involved in heart regeneration. The extracellular component hyaluronic acid and its receptor, hyaluronan-mediated motility receptor (Hmmr), are required in zebrafish for epicardial cell EMT and heart regeneration 177 . The expression patterns of both hyaluronic acid and HMMR were similar in the post-MI infarct area in rats 177 . col12a1b, which encodes nonfibrillar type XII collagen, is expressed in epicardial cells in intact zebrafish hearts and is boosted in cryoinjury wounds 178 . During larval zebrafish spinal cord regeneration, both col12a1a and col12a1b expression and the deposition of collagen type XII are necessary for axon regeneration. Overexpressing col12a1a accelerated spinal cord regeneration 179 . Permanent collagen-enriched scar tissue is a hallmark of mammalian cardiac injury and a roadblock for regeneration, whereas collagen deposition is transient, and potentially beneficial, in injured zebrafish. The reports described here support the possibility that manipulating epicardial ECM components, such as collagens, could improve heart regeneration.
Regenerative capacity of the epicardium After a heart injury, adult epicardial cells proliferate and migrate towards the injury site. A study using a genetic ablation system (tcf21:NTR) to ablate up to 90% of the epicardial cell population in adult zebrafish while sparing the myocardium 149 showed that the epicardium quickly regenerated. Combining this ablation tool with an ex vivo culture system allowed monitoring of epicardial cell behaviour during regeneration in real time 180 ( fig. 3 ). During regeneration, spared epicardial cells proliferated and migrated as a sheet to repopulate the exposed ventricular surface from the ventricular base towards its apex 149 ( fig. 3a) . These regeneration events are probably relevant to the mechanisms by which epicardial cells respond to injury cues. Unexpectedly, the researchers of this study found that the outflow tract (or bulbous arteriosus) is essential for regeneration of the ventricular epicardium ex vivo and that the bulbous NaTuRe Reviews | Cardiology volume 15 | oCToBeR 2018 | 641
arteriosus can guide the direction of regeneration when grafted ectopically. The study further identified Hedgehog ligand derived from the bulbous arteriosus as a likely molecular regulator of these processes. The detailed molecular mechanisms underlying these events are unclear, as is the role of the bulbous arteriosus in epicardial regeneration in vivo. A possibility is that a signalling gradient forms along the bulbous arteriosus and ventricular base-to-apex that guides the regeneration process. Although the regenerative capacity of mammalian epicardium has not been assessed, a strain in mice analogous to the zebrafish tcf21:NTR ablation model, Wt1
CreERT2 ;Rosa26 DTA , was used to ablate epicardial cells in fetal hearts, an injury that decreased fetal cardiac macrophage numbers 122 . Investigating the regenerative capacity and the requirement of the epicardium in adult mammals using genetic ablation tools will be intriguing.
To address cellular mechanisms of epicardial regeneration in zebrafish, Cao et al. live-imaged epicardial regeneration at higher resolution, finding that a subpopulation of polyploid epicardial cells appears at the front of the regenerating tissue ( fig. 3b) . These leader cells are established and maintained by endoreplication, involving genome replication without cell division, and ostensibly eliminated via apoptosis after regeneration 181 . Mechanical tension was much higher at the leading edge ( fig. 3b) , estimated by extrapolating the speed of recoil after laser damage ex vivo to cell membranes, and stretching of epicardial tissue sheets ex vivo could increase the frequency of endoreplication. However, how relevant the ex vivo conclusions on tension are to the in vivo context or what factors (for example, ECM components) might regulate cellular tension is unclear. Small molecules, such as the protein kinase C (Pkc)/RAC serine/ threonine-protein kinase (Akt) inhibitor GSK1007102 and the Hedgehog pathway inhibitor cyclopamine, were identified in screens that either augmented or blocked regenerative responses in explanted zebrafish hearts and cultured epicardial tissue sheets from zebrafish 149, 181 .
Compounds from these screens that modulate epicardial regeneration are potentially useful in dissecting the epicardial injury response and in modulating in vivo cardiac repair.
Therapeutic applications
Directing the adult epicardium Activating the adult epicardium for heart repair requires directing this tissue to promote neovascularization rather than scarring and to function as pro-regenerative rather than pro-inflammatory (fig. 4) . Thymosin β 4 treatment was the first attempt to prime the epicardium in mice 8, 11 , while other studies since have similarly implicated prokineticin 1 and VEGFA 90, 182 . As mentioned above, thymosin β 4 was suggested to regulate epicardial activation through chromatin remodelling 120 . In other cases, these factors are not particularly efficient, and their mechanisms have not been fully explored. Explant culture and screening systems as described above provide an opportunity to identify additional pharmacological factors 149, 180, 181 . A combinatorial approach using multiple factors, ideally aided by viral vectors that can readily access the epicardium, are likely to yield a consensus strategy for boosting proregenerative epicardial properties. This approach might take advantage of regulatory sequences that preferentially direct gene expression in the injured tissue 32, 167 to amplify the production of secreted factors or beneficial ECM components.
Epicardial patches for heart repair
An intriguing study demonstrated that a bioengineered epicardial patch stimulated cardiomyocyte proliferation, diminished infarct size, and improved heart function after MI in mice 169 . In this study, Wei et al. showed that co-culture of an epicardial mesothelial cell line (EMC) with immature cardiomyocytes derived from mouse embryonic stem cells increased cardiomyocyte proliferation. Addition of conditioned medium obtained from the EMCs to the immature cardiomyocyte cell culture mimicked this effect. Implantation of a collagen nanofibrillar patch seeded with conditioned medium to the heart surface immediately after MI in mice improved cardiac function. The active factor in the conditioned medium was later identified as FSTL1, a secreted glycoprotein implicated in suppression of inflammation, reduction of cardiomyocyte apoptosis, promotion of cardiac fibroblast activation, protection of the heart from rupture after MI, and/or attenuation of hypertrophy and cardiac failure after pressure overload [183] [184] [185] [186] . Interestingly, collagen patches without conditioned medium or FSTL1 also improve the outcome after MI, suggesting an important role of interventional physical support therapies for heart repair. FSTL1, which is normally expressed in the epicardium in uninjured hearts, was strongly induced in cardiomyocytes and decreased in the epicardium after MI 169 . By contrast, in another study in mice, FSTL1 was predominantly expressed in fibroblasts of the infarct region 185 . Interestingly, in the study by Wei et al., only epicardium-derived FSTL1 and not myocardial FSTL1 could evoke cardiomyocyte cell division 169 . The researchers of the study speculated that the functional difference between the two sources might be attributable to differential glycosylation. The observation that pro-repair effects were also observed when the patch was applied 1 week after injury has implications for therapies in which patient-specific patches might be generated after diagnosis. Similar effects were observed in a small-scale swine study 169 . Of note, two previous studies in mice, showing reduced infarct size by intravenous delivery of human FSTL1 protein or adenovirus-driven FSTL1 expression before MI, did not assess protein modifications 183, 184 . In addition, cardiomyocyte-specific knockout of Fstl1 in mice was reported to promote hypertrophy in a pressure overload model induced by transverse aortic constriction, suggesting complex cardiac functions of FSTL1 186 . Although the underlying mechanisms require clarification, a paradigm has emerged for how the epicardium might be a source of mitogenic factors for delivery via engineered cardiac patches (fig. 4) .
Assessment of human epicardial biology
Studies exploring epicardial cells of human origin are ultimately essential for translational goals. To this end, van Tuyn and co-authors cultured primary epicardial cells obtained from the right atrial appendages of adult humans and characterized their features 187 . The investigators found that these cells could differentiate into smooth muscle cells when infected with adenoviral vectors expressing genes encoding the transcription factor myocardin or when treated with TGFβ1 or BMP2. However, these cells also spontaneously underwent EMT during culture and attained a fibroblastic morphology. A later study reported a protocol for culturing human fetal and adult EPDCs isolated from cardiac specimens 188 . These cells successfully maintained epithelial features and underwent EMT only after stimulation with TGFβ. The fetal EPDCs were less migratory but progressed faster through EMT than those obtained from adults, and the fetal EPDCs responded to environmental changes more rapidly. Although the mechanism underlying these effects and their translational implications are unclear, this primary cell culture system allows activation and plasticity to be directly assessed in human epicardial cells.
Experiments involving human primary epicardial cells have technical challenges. As an alternative approach, Witty et al. developed a method to generate functional epicardial-like cells from human induced pluripotent stem cells (iPSCs), thus providing an unlimited source of these cells for functional, in vitro studies of the human epicardium 189 . This method also presents the opportunity to develop precision therapies (fig. 4) . With this method, doses of BMP and WNT were manipulated to control cardiovascular lineages of the differentiated human iPSCs. Increases in the dose of BMP4 correlated with reductions in the cardiomyocyte lineage (which was eventually abolished) and an increase in the formation of cells expressing the epicardial markers WT1 and TBX18. After the cells were cultured and passaged for 4 days, the resulting epicardial-like cells formed a confluent monolayer with cobblestone morphology and expressed the tight junction protein ZO1 at cell borders. These cells underwent EMT and differentiated into cells that displayed characteristics of smooth muscle cells in response to treatment with TGFβ1 and basic FGF (bFGF) and of fibroblasts when treated only with bFGF. Thus, the results of this study established a method for inducing epicardial cells from human iPSC cultures.
Following up on that study, Iyer and co-authors developed a chemical method to differentiate epicardium and epicardium-derived smooth muscle cells and fibroblasts from human iPSCs 190 . Human iPSCs were first differentiated to form early mesoderm via a combined treatment including BMP4, FGF2, and Ly294002 (an inhibitor of phosphoinositide 3-kinases). Cells were then treated with BMP4 and FGF2 to induce their differentiation into lateral plate mesoderm, and cells were subsequently treated with BMP4, RA, and WNT3A to induce differentiation into the epicardial lineage. The induced epicardial cells displayed epithelial cell morphology and expressed epicardial markers (that is, TBX18, TCF21, and WT1). These cells underwent EMT and differentiated into smooth muscle cells and fibroblasts upon induction. Interestingly, the cells survived, were incorporated into the epicardium, and even differentiated in vivo when injected into the chick extra-embryonic circulation. Similarly, Guadix et al. used BMP4 and RA to promote the differentiation of human ESCs and human iPSCs into proepicardiallike cells without using WNT 191 . When grafted onto chick embryo hosts, the resulting proepicardial-like cells displayed functional properties, including adhesion and spreading over the myocardium. In the Iyer et al. study, injected cells were predominantly found in the subepicardial space between the epicardium and myocardium; however, Guadix et al. found that the cells generated by their methods spread over the myocardial surface and were incorporated in the epicardium itself, suggesting these cells possess properties closer to those of epithelium. These studies reveal possibilities for transplanting epicardial cells and epicardial-derived lineages for the treatment of heart disease. To avoid the risks of pathogenicity and immunogenic contamination associated with the use of albumin-rich medium, two studies used small-molecule compounds to manipulate RA and WNT signalling in albumin-free media 192, 193 . This approach might make these cells more suitable for clinical applications.
Conclusions
Therapeutic regeneration of the human injured heart is an enormous challenge, and the epicardium is a fairly new player on this stage. One scenario of epicardiumbased approaches is the generation of engineered patches with the appropriate ECM components and tension properties (fig. 4) . Seeded with epicardial and EPDCs, or other cells genetically manipulated to possess the pro-regenerative features of epicardium, these constructs could secrete mitogens and affect neovascularization in injured myocardium. To achieve this goal, more candidate and consensus cardiomyocyte and epicardial mitogens must be identified. Additionally, identification of pro-regenerative subsets of epicardial cells with specific markers will enable genetic methods to manipulate precisely the most appropriate cells after cardiac injury. An additional scenario could influence heart repair with evolved viral vectors that target epicardial cells and their progeny. Marrying more closely the models of high innate heart regeneration with stem cellbased strategies will help to achieve the ultimate goals of epicardial cell research.
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